Draft Guidance for Industry on Developing Medical Imaging Drugs and Biologics; Availability; Reopening of Comment Period

Краткое содержание

The Food and Drug Administration (FDA) is reopening until February 12, 1999, the comment period for the draft guidance for industry entitled ``Draft Guidance for Industry on Developing Medical Imaging Drugs and Biologics'' that appeared in the Federal Register of October 14, 1998 (63 FR 55067). FDA is taking this action in response to a request for an extension.